-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Coya Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2021 to Q3 2025.
- Coya Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$2.43M, a 45.3% increase year-over-year.
- Coya Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$20.6M, a 81.5% decline year-over-year.
- Coya Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$17.2M, a 118% decline from 2023.
- Coya Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$7.9M, a 19.5% increase from 2022.
- Coya Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$9.81M, a 101% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)